The PATHFAST Analyzer helps accelerate urgent cardiac care decisions in the emergency department (ED) with reliable, lab-quality testing at the point of care.
With the PATHFAST Education & Resources Center, we’re providing the materials clinicians need to identify urgent cardiac concerns sooner, help accelerate diagnosis, and improve patient satisfaction.
Polymedco presents “Exploring challenges and opportunities in emergency care: The potential of POC cardiac assays with Dr Robert Christenson.” This Q&A focuses on the challenges faced in quickly assessing and ruling out cardiac events, and how point-of-care (POC) assays from the PATHFAST Analyzer can help transform emergency cardiac care.
Explore the potential of the first and only FDA-cleared POC hs-cTn assay with Dr Christenson.
Watch here
Sep 25-27 | San Diego, CA
As the providers of the first and only POC hs-troponin assay, Polymedco is excited to attend this year’s conference on Quality Beyond the Lab: Navigating POCT Excellence in Patient Care to engage with experts and learn more about new emerging technologies. Visit our booth to learn more about how PATHFAST and hs-cTnI-II, NT-proBNP, D-dimer and other cardiac biomarkers can help your institution enhance patient care.
Presented by Robert H Christenson, PhD, DABCC, FADLM, FACC
This must-see industry workshop will highlight how POC high-sensitivity cardiac troponin (cTn) testing can improve patient and caregiver satisfaction, save system resources, and add value to laboratory medicine services.
Watch on-demand
Robert H Christenson,
PhD, DABCC, FADLM, FACC
Presented by Luca Koechlin, MD
In partnership with:
This webinar will explore the capabilities and benefits of point-of-care (POC) high-sensitivity cardiac troponin (hs-cTn) assays. In contrast to central-laboratory based hs-cTn assays, POC assays such as the PATHFAST hs-cTnI-II eliminate the need for sample transportation and centrifugation. This helps accelerate the diagnosis of acute myocardial infarction (AMI) by reducing the time from blood draw to clinical decision-making.
Register for the webinar to explore the latest evidence supporting POC hs-cTn assays for the early diagnosis of myocardial infarction. Learn more about the new PATHFAST hs-cTnI-II clinical validation to rapidly and effectively rule-out and rule-in of NSTEMI using both a 0/1h and a 0/2h algorithm.
Watch on-demand
Luca Koechlin, MD
Department of Cardiac Surgery & Cardiovascular Research Institute Basel (CRIB), University Hospital Basel
Presented by Christopher R. deFilippi, MD, FACC
Explore the crucial role of NT-proBNP in diagnosing and managing heart failure (HF). Learn about the implications of NT-proBNP levels in the context of renal disease, obesity, and other cardiovascular conditions, and how these levels guide treatment decisions, including the use of sacubitril-valsartan. This session aims to enhance understanding of NT-proBNP’s diagnostic value and its impact on optimizing patient care in heart failure management. This webinar will offer a great learning opportunity for healthcare professionals seeking to deepen their knowledge in managing HF diagnosis, prognostic, and risk assessment.
Watch on-demand
Presented by Fred Apple, PhD
In partnership with:
This webinar will review the latest evidence-based practices surrounding hs-cTn testing, offering insights into assay requirements, result interpretation, clinical integration, and more
Watch on-demand
High-sensitivity cardiac troponin I testing on the PATHFAST analyzer
Learn more about troponin as a biomarker of cardiac injury and discover how PATHFAST hs-cTnI-II can help improve outcomes for patients with suspected acute myocardial infarction (AMI).
Filter by topic
{{ w.date }}
{{ w.desc }}
Thank you. Your document is now available. To download, click here.
Thank you for your submission. Someone will be in touch soon.